@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix Protein: . @prefix hgnc: . @prefix geneProductOf: . @prefix chebi: . @prefix go: . @prefix obo: . @prefix occursIn: . @prefix do: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: hgnc:4274; a Protein: . sub:_2 rdf:object go:0008283; rdf:predicate belv:decreases; rdf:subject chebi:50095; a rdf:Statement . sub:_3 occursIn: do:0060108, obo:CLO_0002140, species:9606; rdf:object sub:_2; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "a(CHEBI:bucladesine) -| bp(GOBP:\"cell proliferation\")", "p(HGNC:GJA1) -> (a(CHEBI:bucladesine) -| bp(GOBP:\"cell proliferation\"))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_5; pav:version "20131211" . sub:_4 prov:value "When Cx43 expression was silenced by siRNA, neither tolbutamide nor dbcAMP were able to up-regulate Cx43 expression (Fig. 6a). Under these circumstances, the effect of tolbutamide and dbcAMP on Ki-67 and p21 expression was analyzed. Our results show that in the absence of Cx43, neither tolbutamide nor dbcAMP are able to decrease the percentage of cells expressing Ki-67 as they do in glioma cells transfected with nontargeting siRNA (Figs. 6b,c)."; prov:wasQuotedFrom pubmed:16718685 . sub:_5 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:16718685; prov:wasDerivedFrom beldoc:, sub:_4 . } sub:pubinfo { this: dct:created "2014-07-03T14:33:00.715+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }